A Study to Evaluate Ocrelizumab Treatment in Participants With Progressive Multiple Sclerosis (CONSONANCE)
Conditions
Diseases of the Nervous System
Volunteers
Health Professionals
What is the purpose of this trial?
Brief Summary:
This study is a prospective, multicenter, open-label, single-arm effectiveness and safety study in participants with progressive multiple sclerosis (PMS).
- Ages18 years - 65 years
- GenderBoth
- Trial withGenentech, Inc.
- Start Date05/18/2021
- End Date09/29/2023
For more information about this study, contact:
Dimitri Duvilaire
I'm interested in volunteering
If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343
Principal Investigator
- Last Updated07/15/2021
- Study HIC#2000024074